The opioid addiction epidemic is introducing a new patient safety risk to healthcare facilities: the possibility of desperate and clever opioid addicts diverting medications from patients, which could leave the provider liable for any consequences.
The FDA has updated the requirements for the pregnancy and lactation sections of drug labeling to allow pregnant women and their healthcare providers to be better informed about the risks and benefits of medications while pregnant or nursing. This article discusses the new Pregnancy and Lactation Labeling Rule that went into effect in June 2015 and is being phased in over the next three to five years.
In 2011, a 57-year-old woman was transferred to a hospital to treat a benign brain tumor. The hospital removed the tumor and prescribed heparin, an anticoagulant medication. However, staff failed to follow proper procedures in the administration of heparin over nine days.
A California hospital was trying to do the right thing when it set up a video camera to catch drug diversion, but it may have ended up violating patient privacy when the cameras recorded patient care and explicit images.
The Centers for Disease Control and Prevention (CDC) assisted state and local health departments in the investigation of the following infection outbreaks stemming from drug diversion activities that involved surgical healthcare providers who tampered with injectable drugs.
Kimberly New, RN, JD, founder of Diversion Specialists in Knoxville, TN, who frequently consults with healthcare facilities on drug diversion, cites the following common areas of weakness in diversion prevention programs:
Healthcare facilities in at least four states alert patients
May 2, 2016
In an all-too-familiar scenario, a healthcare worker charged with diverting drugs in Colorado had a history of moving from facility to facility, which has prompted several other facilities to advise thousands of patients to get tested for bloodborne pathogens.